Clinical Trial Update: Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy [Phase 2]

View source ↗

Summary

This Phase 2 dose-ranging study evaluating weekly CJC-1134-PC in patients with type 2 diabetes mellitus on metformin monotherapy was terminated and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CJC-1134-PC

Snippet

Sponsor: ConjuChem | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: TERMINATED | Results posted: 2017-07-19